Free Trial
OTCMKTS:MYCOF

Mydecine Innovations Group (MYCOF) Stock Price, News & Analysis

→ The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad)
Free MYCOF Stock Alerts
$0.01
+0.01 (+357.14%)
(As of 04/25/2024 ET)
Compare
Today's Range
$0.0108
▼
$0.0128
50-Day Range
$0.00
▼
$0.02
52-Week Range
$0.00
▼
$0.33
Volume
601 shs
Average Volume
22,260 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartHeadlinesShort Interest
MYCOF stock logo

About Mydecine Innovations Group Stock (OTCMKTS:MYCOF)

Mydecine Innovations Group Inc., a biotechnology company, engages in the development and commercialization of psilocybin products for treating mental health problems. The company primarily focuses on treating smoking cessation. Its lead product drug candidates include MYCO-001, MYCO-002, MYCO003, and MYCO-004. Mydecine Innovations Group Inc. has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. The company was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. Mydecine Innovations Group Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.

MYCOF Stock Price History

MYCOF Stock News Headlines

April 18, 2024 | finance.yahoo.com
Mydecine Innovations Group Inc (0NF0.BE)
April 17, 2024 | finance.yahoo.com
Mydecine Innovations Group Inc (0NF0.MU)
April 26, 2024 | Tranzact (Ad)
What is Medicare Supplement Insurance?
Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you.
April 17, 2024 | stockhouse.com
Mydecine Innovations Group Inc. Announces Closing Of Share For Debt Settlement
April 9, 2024 | uk.finance.yahoo.com
Mydecine Innovations Group Inc - SHARE FOR DEBT SETTLEMENT
March 28, 2024 | uk.finance.yahoo.com
Mydecine Innovations Group Inc - Mydecine Innovations Group Inc. Announces Closing of Share for Debt Settlement
March 20, 2024 | finance.yahoo.com
Mydecine Innovations Group Inc. Announces Share for Debt Settlement
February 7, 2024 | finance.yahoo.com
Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds
April 26, 2024 | Colonial Metals (Ad)
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
February 2, 2024 | finance.yahoo.com
Mydecine Innovations Group Announces Director Resignation
December 18, 2023 | uk.finance.yahoo.com
Mydecine Innovations Group Inc - Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound
December 18, 2023 | finance.yahoo.com
Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound
November 29, 2023 | finanznachrichten.de
Mydecine Innovations Group Inc.: Mydecine Announces Update Regarding the Special Access Program
November 28, 2023 | finance.yahoo.com
Mydecine Announces Update Regarding the Special Access Program
November 17, 2023 | finance.yahoo.com
Canadian Securities Exchange Reports October 2023 Performance Figures
October 31, 2023 | finance.yahoo.com
Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements
October 26, 2023 | finanznachrichten.de
Mydecine Innovations Group Inc.: Mydecine Provides Q4 2023 Business Update
October 26, 2023 | financialpost.com
Mydecine Provides Q4 2023 Business Update
October 25, 2023 | lse.co.uk
Mydecine Innovations Group Inc Share Price (MYIG.PL)
October 16, 2023 | proactiveinvestors.com
Mydecine Innovations Group gearing up for human trials after completing Aquis listing
October 13, 2023 | finanznachrichten.de
Mydecine Innovations Group Inc - Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK
October 12, 2023 | benzinga.com
Psychedelic-Based Drugs Biotech Company Begins Trading On UK's AQSE Growth Market
October 12, 2023 | finanznachrichten.de
Mydecine Innovations Group Inc.: Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK
October 12, 2023 | finance.yahoo.com
Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK
October 5, 2023 | finance.yahoo.com
Mydecine Innovations Group Announces Listing on the Canadian Securities Exchange and Delisting from the NEO
September 28, 2023 | finanznachrichten.de
Mydecine Innovations Group Inc.: Mydecine Innovations Group Announces Expected U.K. Dual Listing Admission Date
September 19, 2023 | finance.yahoo.com
Mydecine Innovations Announces Closing of Prospectus Supplement Financing
See More Headlines
Receive MYCOF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mydecine Innovations Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/16/2021
Today
4/26/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
OTCMKTS:MYCOF
CUSIP
N/A
CIK
N/A
Web
www.mydecine.com
Phone
(604) 687-2038
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. David Joshua Bartch (Age 36)
    Co-Founder, CEO, President & Chairman of the Board
    Comp: $327.28k
  • Mr. Robert Roscow M.A.
    Co-Founder, Chief Scientific Officer & Director
  • Mr. Damon Michaels
    Co-Founder & COO
  • Mr. John Charles Ross CA (Age 66)
    CPA, M.B.A., CFO & Corporate Secretary
    Comp: $6.77k
  • Mr. Sanford M. Stein
    Chief Compliance Officer & General Counsel
  • Dr. Rakesh Jetly FRCPC
    M.D., Chief Medical Officer
  • Morgan Kervitsky
    Director of Marketing
  • Mr. Michel Rudolphie
    President of the European Operations
  • Mr. William Cook
    Interim CEO & Technical Director of Mindleap Health Inc.

Key Competitors

View All Competitors

MYCOF Stock Analysis - Frequently Asked Questions

How have MYCOF shares performed in 2024?

Mydecine Innovations Group's stock was trading at $0.0149 at the start of the year. Since then, MYCOF shares have decreased by 14.1% and is now trading at $0.0128.
View the best growth stocks for 2024 here.

Are investors shorting Mydecine Innovations Group?

Mydecine Innovations Group saw a decrease in short interest during the month of March. As of March 15th, there was short interest totaling 100 shares, a decrease of 99.0% from the February 29th total of 9,900 shares. Based on an average trading volume of 37,700 shares, the days-to-cover ratio is presently 0.0 days.
View Mydecine Innovations Group's Short Interest.

How were Mydecine Innovations Group's earnings last quarter?

Mydecine Innovations Group Inc. (OTCMKTS:MYCOF) announced its quarterly earnings data on Tuesday, November, 16th. The company reported ($1.00) earnings per share for the quarter, missing analysts' consensus estimates of ($0.50) by $0.50.

When did Mydecine Innovations Group's stock split?

Mydecine Innovations Group shares reverse split on the morning of Thursday, April 21st 2022. The 1-50 reverse split was announced on Thursday, April 21st 2022. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, April 21st 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

How do I buy shares of Mydecine Innovations Group?

Shares of MYCOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:MYCOF) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
These AI trades triggered this morning (545% return)
Prosper Trading Academy
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Rich Dad Poor Dad Author Shocks Millions With 2024 Crash Warning
American Hartford Gold Group
Trump is sounding the alarm
Preserve Gold